Department of Cardiology, University of Health Sciences, Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Training and Research Hospital, İstanbul, Turkey.
Department of Cardiology, University of Health Sciences, Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Training and Research Hospital, İstanbul, Turkey.
Ann Vasc Surg. 2022 May;82:172-180. doi: 10.1016/j.avsg.2021.11.008. Epub 2021 Dec 10.
Chronic limb-threatening ischemia (CLTI), which presents with ischemic rest pain, ulceration, or gangrene, is a complex form of peripheral artery disease that can cause mortality and amputation. C-reactive protein (CRP), an inflammatory marker, indicates vascular inflammation resulting from the cytokine-dependent inflammatory process in the arterial wall, and arterial atherosclerosis resulting from the inflammation. Lower albumin levels are also associated with peripheral artery disease. We investigated the association between CRP/Albumin ratio (CAR) and long-term mortality in patients with CLTI.
A total of 172 patients who underwent endovascular treatment (EVT) for below the knee (BTK) lesions were enrolled in this study. Patients with acute infection requiring antibiotic therapy, chronic inflammatory disease, end-stage liver disease, malignancy were excluded from the study. Besides, patients with pre-follow-up intervention to the same vascular bed were also excluded from the study. The primary endpoint of the study was all-cause mortality. Patients were divided into 2 groups according to mortality.
A total of 70 patients (40.6%) died during 32 ± 21 months of follow-up in the present study. The major amputation rate was 21.5%. The mortality (+) group was older and had higher rates of congestive heart failure, chronic kidney disease, history of stroke, and CRP levels. Moreover, statin and ACE inhibitor/angiotensin receptor blocker (ACE/ARB) use, GFR, and albumin levels were lower in the mortality (+) group. CAR was significantly higher in the mortality (+) group when comparing both groups (3.25 [1.46 - 7.86] vs. 9.75 [4.5 - 17.71], P < 0.001). CAR, congestive heart failure, chronic kidney disease, history of stroke, ACE/ARB, or statin use were independent predictors of all-cause mortality in multivariable Cox regression analysis.
CAR was associated with mortality in CLTI patients undergoing EVT for BTK lesions. CAR may be a simple method to help patient selection, assessment, and intervention strategy for EVT and may improve patient outcomes.
慢性肢体威胁性缺血(CLTI)表现为缺血性静息痛、溃疡或坏疽,是一种外周动脉疾病的复杂形式,可导致死亡率和截肢。C 反应蛋白(CRP)是一种炎症标志物,表明血管炎症是由动脉壁中细胞因子依赖的炎症过程引起的,动脉粥样硬化是由炎症引起的。较低的白蛋白水平也与外周动脉疾病有关。我们研究了 CRP/白蛋白比值(CAR)与 CLTI 患者长期死亡率之间的关系。
本研究共纳入 172 例接受膝下(BTK)病变血管内治疗(EVT)的患者。患有需要抗生素治疗的急性感染、慢性炎症性疾病、终末期肝病、恶性肿瘤的患者被排除在研究之外。此外,在随访前对同一血管床进行介入治疗的患者也被排除在研究之外。本研究的主要终点是全因死亡率。根据死亡率将患者分为 2 组。
在本研究的 32±21 个月随访期间,共有 70 例(40.6%)患者死亡。主要截肢率为 21.5%。死亡率(+)组年龄较大,充血性心力衰竭、慢性肾脏病、中风史和 CRP 水平较高。此外,死亡率(+)组他汀类药物和血管紧张素转换酶抑制剂/血管紧张素受体阻滞剂(ACE/ARB)的使用、肾小球滤过率和白蛋白水平较低。比较两组时,死亡率(+)组的 CAR 明显更高(3.25[1.46-7.86]比 9.75[4.5-17.71],P<0.001)。多变量 Cox 回归分析显示,CAR、充血性心力衰竭、慢性肾脏病、中风史、ACE/ARB 或他汀类药物的使用是全因死亡率的独立预测因素。
CAR 与接受 EVT 治疗 BTK 病变的 CLTI 患者的死亡率相关。CAR 可能是一种简单的方法,可以帮助选择、评估和干预 EVT 策略,并可能改善患者的预后。